Sanuo Biology: Disclosure of the shareholding situation of the top ten shareholders and unlimited sales condition shareholders before the repurchase of shares.

Shennuo Biology announced that the company held a board meeting on March 27, 2026, agreeing to use its own funds to repurchase shares through centralized competitive bidding to be used for cancellation and reduction of registered capital. The company will convene an extraordinary general meeting on April 13 to consider the proposal, with the record date of April 7. The announcement disclosed the names, shareholdings, and percentages of the top ten shareholders and the top ten unrestricted shareholders registered on that day. As of April 7, the company's repurchase special securities account held 19,176,800 shares of the company, accounting for 3.42% and 4.25% of the total share capital and the total number of unrestricted shares, respectively.